cube one was a guest at the departmental fair of an internationally researching pharmaceutical company. The invitation gave us the chance to present our GxP expertise where it matters day to day: in direct conversation with specialists on site.
Why GLP matters in the pre-clinical phase
Before a substance enters clinical trials in humans, its safety must be demonstrated robustly in the laboratory and in pre-clinical studies. GLP does not govern the scientific question itself, but the structure behind it: studies must be plannable, executable, documented and archivable: aiming for absolute data integrity and comparable results.
What we showed on site
At the booth we showed how cube one supports teams in the GxP environment as a partner, from data-integrity auditing through equipment and facility qualification to computerised system validation (CSV).
- Data integrity and auditing in day-to-day laboratory work
- Qualification of equipment and facilities
- computer system validation (CSV) for GxP systems
Exchange as equals
In-house fairs like this are valuable for us because they enable dialogue with the specialist departments: close to the concrete challenges of daily work. We thank the hosting team for the exchange and the insights into laboratory practice.
You can learn more about us on About cube one. To discuss GLP, data integrity or validation, please use our contact page.
Further reading
The original post is available on the cube one company page on LinkedIn: LinkedIn update on the departmental fair.